110
Views
7
CrossRef citations to date
0
Altmetric
Original Research

The expression of microRNA 146a in patients with ischemic stroke: an observational study

, , , , , & show all
Pages 273-278 | Published online: 09 Aug 2019

References

  • Béjot Y, Daubail B, Giroud M. Epidemiology of stroke and transient ischemic attacks: current knowledge and perspectives. Rev Neurol (Paris). 2016;172(1):59–68. doi:10.1016/j.neurol.2015.07.01326718592
  • Katan M, Luft A. Global burden of stroke. Semin Neurol. 2018. doi:10.1055/s-0038-1649503
  • Sacco RL, Kasner SE, Broderick JP, et al. An updated definition of stroke for the 21st century: a statement for healthcare professionals from the American heart association/American stroke association. Stroke. 2013. doi:10.1161/STR.0b013e318296aeca
  • Meschia JF, Brott T. Ischaemic stroke. Eur J Neurol. 2018;25(1):35–40. doi:10.1111/ene.1340928800170
  • Hasan TF, Rabinstein AA, Middlebrooks EH, et al. Diagnosis and management of acute ischemic stroke. Mayo Clin Proc. 2018;93(4):523–538. doi:10.1016/j.mayocp.2018.02.01329622098
  • van der Worp HB, Raaijmakers TWMD, Kappelle LJ. Early complications of ischemic stroke. Curr Treat Options Neurol. 2008;10(6):440–449. Available from: http://www.ncbi.nlm.nih.gov/pubmed/18990312. Accessed April 8, 2019.18990312
  • Civelek GM, Atalay A, Turhan N. Medical complications experienced by first-time ischemic stroke patients during inpatient, tertiary level stroke rehabilitation. J Phys Ther Sci. 2016;28(2):382–391. doi:10.1589/jpts.28.38227065523
  • Roth EJ, Lovell L, Harvey RL, Heinemann AW, Semik P, Diaz S. Incidence of and risk factors for medical complications during stroke rehabilitation. Stroke. 2001. doi:10.1161/01.STR.32.2.523
  • Musuka TD, Wilton SB, Traboulsi M, Hill MD. Diagnosis and management of acute ischemic stroke: speed is critical. CMAJ. 2015. doi:10.1503/cmaj.140355
  • Erbguth F. Stroke mimics and stroke chameleons: differential diagnosis of stroke. Fortschritte der Neurol Psychiatr. 2017. doi:10.1055/s-0043-111889
  • Chiu AH, Phillips TJ, Phatouros CC, et al. CT perfusion in acute stroke calls: a pictorial review and differential diagnoses. J Med Imaging Radiat Oncol. 2016. doi:10.1111/1754-9485.12422
  • Cucchiara B, Nyquist P. Blood markers in TIA: array of hope? Neurology. 2011. doi:10.1212/WNL.0b013e318236f110
  • Liu J. Control of protein synthesis and mRNA degradation by microRNAs. Curr Opin Cell Biol. 2008. doi:10.1016/j.ceb.2008.01.006
  • Bourassa MW, Ratan RR. The interplay between microRNAs and histone deacetylases in neurological diseases. Neurochem Int. 2014. doi:10.1016/j.neuint.2014.03.012
  • Mocellin S, Pasquali S, Pilati P. Oncomirs: from tumor biology to molecularly targeted anticancer strategies. Mini Rev Med Chem. 2009. doi:10.2174/138955709787001802
  • Khoshnam SE, Winlow W, Farbood Y, Moghaddam HF, Farzaneh M. Emerging roles of microRNAs in ischemic stroke: as possible therapeutic agents. J Stroke. 2017;19(2):166–187. doi:10.5853/jos.2016.0136828480877
  • Iyer A, Zurolo E, Prabowo A, et al. MicroRNA-146a: a key regulator of astrocyte-mediated inflammatory response. PLoS One. 2012;7(9):e44789. doi:10.1371/JOURNAL.PONE.004478923028621
  • Von Elm E, Altman DG, Egger M, et al. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies*. Int J Surg. 2014;12(12):1495–1499. doi:10.1016/j.ijsu.2014.07.01325046131
  • Shahpouri MM, Mousavi SA, Khorvash F, Mousavi SM, Hoseini T. Anticoagulant therapy for ischemic stroke: a review of literature. J Res Med Sci. 2012;17(4):396–401.23267405
  • Teasdale G, Jennett B. Assessment of coma and impaired consciousness. A practical scale. Lancet. 1974. doi:10.1016/S0140-6736(74)91639-0
  • Li X, Gibson G, Kim JS, et al. MicroRNA-146a is linked to pain-related pathophysiology of osteoarthritis. Gene. 2011. doi:10.1016/j.gene.2011.03.003
  • Li S-H, Su S-Y, Liu J-L. Differential regulation of microRNAs in patients with ischemic stroke. Curr Neurovasc Res. 2015;12(3):214–221. doi:10.2174/156720261266615060512170926044809
  • Zhu R, Liu X, He Z, Li Q. miR-146a and miR-196a2 polymorphisms in patients with ischemic stroke in the Northern Chinese Han population. Neurochem Res. 2014;39(9):1709–1716. doi:10.1007/s11064-014-1364-524952884
  • Jeon YJ, Kim OJ, Kim SY, et al. Association of the miR-146a, miR-149, miR-196a2, and miR-499 polymorphisms with ischemic stroke and silent brain infarction risk. Arterioscler Thromb Vasc Biol. 2013;33(2):420–430. doi:10.1161/ATVBAHA.112.30025123202363
  • Li C-X, Weng H, Zheng J, Feng Z-H, Ou J-L, Liao W-J. Association between microRNAs polymorphisms and risk of ischemic stroke: a meta-analysis in Chinese individuals. Front Aging Neurosci. 2018;10:82. doi:10.3389/fnagi.2018.0008229643803
  • Zhou X, Su S, Li S, et al. MicroRNA-146a down-regulation correlates with neuroprotection and targets pro-apoptotic genes in cerebral ischemic injury in vitro. Brain Res. 2016. doi:10.1016/j.brainres.2016.07.034
  • Su Z-F, Sun Z-W, Zhang Y, Wang S, Yu Q-G, Wu Z-B. Regulatory effects of miR-146a/b on the function of endothelial progenitor cells in acute ischemic stroke in mice. Kaohsiung J Med Sci. 2017;33(8):369–378. doi:10.1016/J.KJMS.2017.05.01028811005
  • Liu XS, Chopp M, Pan WL, et al. MicroRNA-146a promotes oligodendrogenesis in stroke. Mol Neurobiol. 2017;54(1):227–237. doi:10.1007/s12035-015-9655-726738853
  • Martinez B, Peplow P. Immunomodulators and microRNAs as neurorestorative therapy for ischemic stroke. Neural Regen Res. 2017;12(6):865. doi:10.4103/1673-5374.20854028761412